Moderna Inc. (MRNA.USD)
SIX
160.60
+21.80 (+15.71%)
Real-time Data
07:00 AM
Day's Range
160.60160.60
52 wk Range
40.64160.60
Overview - MRNA.USD - Moderna Inc.
Key Statistics
Trading
Volume
4.59K
Peers - MRNA.USD - Moderna Inc.
Peer Comparison
Compared with companies in Biotechnology listed on SIX.
- MRNA.USDSIXModerna, Inc.+13.90%52-week change—P/E (Trailing)—Profit Margin
- BIONSIXBB Biotech AG+42.23%52-week change2.29P/E (Trailing)‪127.31%‬Profit Margin
- BSLNSIXBasilea Pharmaceutica Ltd+32.82%52-week change17.13P/E (Trailing)‪21.17%‬Profit Margin
- BIOVSIXBioVersys AG-8.78%52-week change-6.84P/E (Trailing)‪-386.62%‬Profit Margin
- ADXNSIXAddex Therapeutics Ltd-145.53%52-week change-0.41P/E (Trailing)‪0.00%‬Profit Margin
- ARECSIXAbrdn Future Education & Learning UCITS ETF+11.20%52-week change—P/E (Trailing)—Profit Margin
- BOLDSIX21Shares Bitcoin Gold ETP+6.71%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - MRNA.USD - Moderna Inc.
About
Moderna, Inc. is a biotechnology company specializing in the development of transformative medicines using messenger ribonucleic acid (mRNA) technology. Its primary focus lies in creating innovative therapeutics across multiple modalities, including prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology…
SectorHealthcare
IndustryBiotechnology
Employees4.70K
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
